Table 2 Left ventricular dimensions and function in the study population
From: Cardiac steatosis and left ventricular function in men with metabolic syndrome
MetS present (n = 37) | MetS absent (n = 38) | p | |
|---|---|---|---|
Systolic function and dimensions | |||
LV ejection fraction (%) | 61 ± 6 | 62 ± 4 | 0.745 |
LV end-systolic volume/Body surface area (mL/ m2) | 25 ± 7 | 32 ± 5 | <0.001 |
LV stroke volume/Body surface area (mL/m2) | 40 ± 8 | 52 ± 7 | <0.001 |
LV mass/Body surface area (g/m2) | 58 ± 9 | 62 ± 7 | 0.190 |
LV mass/End-diastolic volume (g/mL) | 0.88 (0.66-1.32) | 0.73 (0.61-0.90) | <0.001 |
LV global functional index (%) | 41 (24-51) | 44 (35-54) | <0.001 |
Diastolic function and dimensions | |||
LV end-diastolic volume/Body surface area (mL/m2) | 65 ± 13 | 84 ± 11 | <0.001 |
Peak filling rate (mL/s) | 471 (238-909) | 667 (329-1315) | 0.002 |
Peak filling rate/LV end-diastolic volume (s-1) | 3.37 (1.89-5.46) | 3.75 (2.63-7.23) | 0.023 |
LV early diastole (%) | 68 ± 9 | 78 ± 8 | 0.001 |